AI can effectively exclude pathology in chest X-rays

A commercial artificial intelligence (AI) tool used off-label was effective at excluding pathology and had equal or lower rates of critical misses on chest X-ray than radiologists, according to a study published today in Radiology, a journal of the Radiological Society of North America (RSNA).

BI-765179 by Boehringer Ingelheim International for Non-Small Cell Lung Carcinoma: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 6, 2023

Opinion | Healthcare Unionization Isn’t the Only Option

Greenglass is a retired primary care physician and physician manager. Unions have been a hot topic in the media in the last several months. Unionization

September 26, 2024

Washington State Hospitalists Set to Unionize

A group of hospitalists in Washington state is poised to become the first physician union to earn joint-employer status, sources told MedPage Today. Some 30

May 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.